How Concerned Should Psychotherapists Be?
By Tori Rodriguez - The more marijuana legalization reaches mainstream acceptance, the more the divisions of opinion within the mental health field—presumably the professionals who have the most scientifically informed perspective on the debate—become apparent.
Could a Psychedelic Drug Be the Next Big Thing in Treatment?
By Ryan Howes - Michael Mithoefer, a clinical faculty member at the Medical University of South Carolina, has demonstrated remarkable early results using MDMA as a therapist-supervised treatment for chronic PTSD. His work is being approved by the FDA and could eventually clear a path for MDMA treatment clinics specializing in trauma.
Fast-Acting Party Drug Could be in the Pipeline for Depression Treatment
Since it was introduced as an anesthetic in the 1970s, ketamine has occupied an uncertain pharmacological status. It’s been used as both a Vietnam-era battlefield painkiller and an illicit party drug, better known as Special K. But recent findings in studies around the world have some researchers wondering whether it might be the silver bullet for depression that Prozac and its sidekicks never turned out to be.
Page 1 of 1 (3 Blog Posts)